We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.36B
AUM Growth
+$242M
Cap. Flow
+$103M
Cap. Flow %
4.35%
Top 10 Hldgs %
34.74%
Holding
3,215
New
293
Increased
1,348
Reduced
581
Closed
158
Avg Time Held Equity + Options
2.6 years
Top 10 Avg Time Held Equity + Options
1.9 years
Top 20 Avg Time Held Equity + Options
2.2 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
1.9 years
Top 20 Avg Time Held Equity only
2.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.15%
2 Technology 15.95%
3 Financials 7.59%
4 Healthcare 5.97%
5 Communication Services 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MRTX
2876
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1K ﹤0.01%
5
-18
-78% -$2.89K
2020 Q3
3 quarters
HT
2877
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$1K ﹤0.01%
75
– –
2017 Q1
17 quarters
CCF
2878
DELISTED
Chase Corporation
CCF
$1K ﹤0.01%
14
– –
2020 Q1
5 quarters
TRHC
2879
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1K ﹤0.01%
11
– –
2021 Q1
1 quarter
DEN
2880
DELISTED
Denbury Inc.
DEN
$1K ﹤0.01%
+13
New +$792
2021 Q2
0 quarters
RAD
2881
DELISTED
Rite Aid Corporation
RAD
$1K ﹤0.01%
37
– –
2020 Q4
2 quarters
SURF
2882
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
+137
New +$1.06K
2021 Q2
0 quarters
ACGN
2883
DELISTED
Aceragen Inc
ACGN
$1K ﹤0.01%
+59
New +$1.19K
2021 Q2
0 quarters
SQZ
2884
DELISTED
SQZ Biotechnologies Company
SQZ
$1K ﹤0.01%
+74
New +$967
2021 Q2
0 quarters
USX icon
2885
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$1K ﹤0.01%
+105
New +$1.12K
2021 Q2
0 quarters
ONCR
2886
DELISTED
Oncorus, Inc.
ONCR
$1K ﹤0.01%
+59
New +$911
2021 Q2
0 quarters
SGTX
2887
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$1K ﹤0.01%
+7
New +$1.23K
2021 Q2
0 quarters
CDAK
2888
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$1K ﹤0.01%
+42
New +$807
2021 Q2
0 quarters
SRNE
2889
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1K ﹤0.01%
77
– –
2020 Q4
2 quarters
IVC
2890
DELISTED
Invacare Corporation
IVC
$1K ﹤0.01%
128
– –
2019 Q1
9 quarters
EAR
2891
DELISTED
Eargo, Inc. Common Stock
EAR
$1K ﹤0.01%
+1
New +$838
2021 Q2
0 quarters
CLVS
2892
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
100
– –
2018 Q4
10 quarters
IPOD
2893
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$1K ﹤0.01%
100
– –
2021 Q1
1 quarter
IPOF
2894
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$1K ﹤0.01%
100
– –
2020 Q4
2 quarters
EPZM
2895
DELISTED
Epizyme, Inc
EPZM
$1K ﹤0.01%
134
– –
2021 Q1
1 quarter
BTNB
2896
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
$1K ﹤0.01%
+100
New +$1.02K
2021 Q2
0 quarters
MEUSW
2897
DELISTED
23andMe Holding Co Warrant
MEUSW
$1K ﹤0.01%
+333
New +$666
2021 Q2
0 quarters
ITMR
2898
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$1K ﹤0.01%
25
– –
2020 Q3
3 quarters
SKINW icon
2899
DELISTED
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
$1K ﹤0.01%
+214
New +$918
2021 Q2
0 quarters
KIN
2900
DELISTED
Kindred Biosciences, Inc.
KIN
$1K ﹤0.01%
+109
New +$634
2021 Q2
0 quarters

Similar funds

Parallel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Parallel Advisors held 3,215 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $103M of net new capital in Q2 2021, opening 293 new positions and adding to 1,348 existing holdings. Its largest new stake was U.S. Core Equity 2 Portfolio ETF Class Shares: 118,367 shares worth $3.19M.

By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $8.53M trimmed.

  • Parallel Advisors's largest Q2 2021 buy was U.S. Core Equity 2 Portfolio ETF Class Shares: 118,367 shares worth $3.19M.
  • Parallel Advisors added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $14.3M increase.
  • Parallel Advisors's biggest Q2 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $8.53M.
  • Parallel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $365K.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.36B portfolio in Q2 2021.
  • Parallel Advisors opened 293 new positions and closed 158 in Q2 2021.
  • Parallel Advisors's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.